Investor Relations


Scroll
Announcements

All

2022
2023
2024
2025
2026
  • 2026.09.04 VOLUNTARY ANNOUNCEMENT The Approval of LuX-Valve Plus by the Hong Kong Department of Health
  • 2026.09.04 Monthly Return of Equity Issuer on Movements in Securities for the month ended 31 August 2026
  • 2026.08.31 INTERIM RESULTS ANNOUNCEMENT FOR THE SIX MONTHS ENDED 30 JUNE 2026
  • 2026.08.31 REVISION OF ANNUAL CAPS UNDER THE MEDICAL DEVICES ACCESSORIES PURCHASE AGREEMENT
  • 2026.08.19 NOTICE OF BOARD MEETING
  • 2026.08.10 INSIDE INFORMATION FORECAST OF 2026 INTERIM REVENUE
  • 2026.08.06 Monthly Return of Equity Issuer on Movements in Securities for the month ended 31 July 2026
  • 2026.07.16 VOLUNTARY ANNOUNCEMENT THE SUCCESSFUL COMPLETION OF FIRST BATCH OF IMPLANTATION IN THE FDA IDE PIVOTAL TRIAL FOR LUX-VALVE PLUS
  • 2026.07.08 VOLUNTARY ANNOUNCEMENT LuX-Valve Plus Obtained the EU MDR CE Certification
  • 2026.07.07 Monthly Return of Equity Issuer on Movements in Securities for the month ended 30 June 2026